Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review Paola GhanemKristen MarroneRakhi P. Naik Review Article 28 December 2021 Pages: 1 - 10
Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis Pallavi PatwardhanAdrienne LandsteinerAdam Cuker Original Article Open access 10 September 2021 Pages: 11 - 19
The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction Mitchell DavisMohammad Reza MovahedMehrnoosh Hashemzadeh Original Article 01 October 2021 Pages: 21 - 26
miRNA profile and disease severity in patients with sickle cell anemia Thaís Priscila BiassiElvira Maria Guerra-ShinoharaMaria Stella Figueiredo Original Article 22 October 2021 Pages: 27 - 34
Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome Nazim YildirimSelma UnalYesim Oztas Original Article 25 September 2021 Pages: 35 - 41
Prevalence of and risk factors for obstructive sleep apnea in children with sickle cell: a multicentric cross sectional study Albraa AbulhamailAhmad AlShebliBahaa Abaalkhail Original Article 10 September 2021 Pages: 43 - 57
Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era Julio del Río-GarmaSabela Bobillofor the “Registro Español de la Púrpura Trombocitopénica Trombótica (REPTT)”, and the “Grupo Español de Aféresis (GEA)” Original Article 12 October 2021 Pages: 59 - 67
Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India Anshul GuptaNihar DesaiMansi Gupta Original Article 24 September 2021 Pages: 69 - 79
Ixazomib, lenalidomide, and dexamethasone combination in “real-world” clinical practice in patients with relapsed/refractory multiple myeloma Juraj SokolTomas GumanJan Stasko Original Article 22 September 2021 Pages: 81 - 89
Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma Xiaojun WangYi MiaoXiaoli Feng Original Article 04 October 2021 Pages: 91 - 97
Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease Ryan C. W. HoThomas S. Y. ChanYok-Lam Kwong Original Article 12 November 2021 Pages: 99 - 108
Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015 Hsin-An HouHuey-En TzengLi-Nien Chien Original Article 13 October 2021 Pages: 109 - 118
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation Peng ZhaoMing NiJishi Wang Original Article Open access 27 September 2021 Pages: 119 - 130
Real-world survival of US patients with intermediate- to high-risk myelofibrosis: impact of ruxolitinib approval Srdan VerstovsekShreekant ParasuramanClaire Harrison Original Article Open access 09 October 2021 Pages: 131 - 137
Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared with real-world data Andrew T. KuykendallLibo SunRami Komrokji Original Article 08 October 2021 Pages: 139 - 146
Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting Fernanda Rodrigues MendesWellington Fernandes da SilvaEduardo Magalhaes Rego Original Article 21 October 2021 Pages: 147 - 154
Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre Garret M. K. LeungJoycelyn P. Y. SimYok-Lam Kwong Original Article 12 November 2021 Pages: 155 - 163
Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation Nobuhiro HiramotoHirohito Yamazakion behalf of the Adult Aplastic Anemia Working Group of the Japanese Society for Hematopoietic Cell Transplantation Original Article 21 September 2021 Pages: 165 - 175
Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies Takaaki KonumaJun OoiSatoshi Takahashi Original Article 30 September 2021 Pages: 177 - 189
Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation: a nationwide study Małgorzata Salamonowicz-BodziochJowita FrączkiewiczJan Styczyński Original Article Open access 21 October 2021 Pages: 191 - 201
Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study Khaled M. MusallamMaria Domenica CappelliniAli T. Taher Letter to the Editor 20 January 2021 Pages: 203 - 204
Dose-adjusted high-dose chemotherapy with autologous stem cell transplantation for elderly (≥ 70 years old) lymphoma patients Hiroki HosoiShogo MurataTakashi Sonoki Letter to the Editor 06 January 2021 Pages: 205 - 207
Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study Satoshi YamasakiTakumi MatsushimaHiromi Iwasaki Letter to the Editor 03 January 2021 Pages: 209 - 211
Intracranial hemorrhage as presentation of chronic lymphocytic leukemia successfully treated with ibrutinib Fernando Martín-MoroMónica García-CosíoFrancisco Javier López-Jiménez Letter to the Editor 09 January 2021 Pages: 213 - 215
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient Sebastian SchlaweckPeter BrossartAnnkristin Heine Letter to the Editor Open access 12 January 2021 Pages: 217 - 218
Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail Pierre-Edouard DebureauxMathilde RuggiuPierre Lemaire Letter to the Editor 08 January 2021 Pages: 219 - 221
CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma Harinder GillRex Au-YeungYok-Lam Kwong Letter to the Editor 24 March 2021 Pages: 223 - 226
Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia Gloria AcquavivaGiovanna NonneClaudio Fozza Letter to the Editor 19 January 2021 Pages: 227 - 228
HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19 Luca RoncatiAntonio ManentiAntonio Maiorana Letter to the Editor 18 January 2021 Pages: 229 - 231
The first case of a collision tumor of gastrointestinal stromal tumor and intravascular large B cell lymphoma Yueying YuanEn-Hua WangLiang Wang Letter to the Editor 18 January 2021 Pages: 233 - 235
Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies Masatoshi SakuraiYasuhito NannyaTakehiko Mori Letter to the Editor 18 January 2021 Pages: 237 - 239
Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds Immacolata TartaglioneRenzo ManaraSilverio Perrotta Letter to the Editor 04 February 2021 Pages: 241 - 242